Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

ConclusionsTrifarotene was effective and well tolerated in treating moderate-to-severe facial acne and reducing atrophic acne scars, with reduction of total atrophic scar count as early as week 2.Trial RegistrationClinicaltrials.gov NCT04856904.

Source: Dermatology and Therapy - October 15, 2023 Category: Dermatology Source Type: research